18.1 Inhalant Use Disorder: Volatile Solvents, Nitrous Oxide & Alkyl Nitrites

18.1 Inhalant Use Disorder: Volatile Solvents, Nitrous Oxide & Alkyl Nitrites

Quick Answer: Inhalants are legal, cheap household and industrial products used for intoxication. Sudden sniffing death syndrome — catecholamine sensitization of the myocardium by halogenated hydrocarbons producing ventricular fibrillation during startle or exertion — can kill on a first use. Toluene causes normal anion gap (distal renal tubular) acidosis with severe hypokalemia and irreversible leukoencephalopathy. Nitrous oxide irreversibly oxidizes cobalamin, inactivating methionine synthase and producing subacute combined degeneration with a normal serum B12 and elevated methylmalonic acid. Alkyl nitrites (poppers) cause methemoglobinemia and are absolutely contraindicated with PDE-5 inhibitors.

Inhalants sit in blueprint category E (other use disorders, 9%, 13 to 15 items) alongside prescription drugs, hallucinogens, designer drugs and process addictions. They are the class most likely to be skipped in preparation and therefore among the highest-yield content per hour studied.

---

1. The Four Pharmacologic Groups

Key distinction: nitrites are used almost exclusively for smooth muscle relaxation and sexual enhancement, not for central intoxication, and their toxicity profile is entirely different from solvents.

---

2. Sudden Sniffing Death Syndrome

1. Halogenated and aliphatic hydrocarbons sensitize the myocardium to endogenous catecholamines.
2. A surge of catecholamines — from being startled, fleeing, or exerting — triggers ventricular tachycardia or fibrillation.
3. Death can occur on a first exposure, in a healthy adolescent, with no prior warning signs.

Management implications that are directly testable:

• Approach a person who is actively inhaling calmly and without startling them.
• In inhalant-associated arrest, avoid catecholamines where feasible; beta-blockade (esmolol) is the preferred approach for hydrocarbon-sensitized dysrhythmia, in contrast to standard protocols.
• Teach caregivers that "he only did it once" offers no protection.

---

3. Toluene: The Two Classic Syndromes

Renal tubular acidosis

Chronic toluene inhalation produces a distal (type 1) renal tubular acidosis: normal anion gap metabolic acidosis with severe hypokalemia, often presenting as profound muscle weakness or frank paralysis, sometimes with rhabdomyolysis. Look for the combination of a young patient, paint on the hands or face, weakness, potassium near 2 mEq/L, and a normal anion gap — a normal anion gap is the discriminator from methanol, ethylene glycol and ketoacidosis.

Leukoencephalopathy

Chronic toluene exposure damages cerebral white matter, producing ataxia, tremor, cognitive decline, dysarthria and optic neuropathy, with characteristic MRI white matter changes. These deficits are largely irreversible, which makes early identification and cessation the only effective intervention.

Other solvent-specific injuries

• n-Hexane (some glues, rubber cement): distal symmetric peripheral neuropathy through its 2,5-hexanedione metabolite.
• Trichloroethylene and carbon tetrachloride: hepatotoxicity and nephrotoxicity.
• Benzene (some gasoline products): aplastic anemia and leukemia.
• Methylene chloride (paint stripper): metabolized to carbon monoxide, producing delayed and prolonged carboxyhemoglobin elevation.

---

4. Nitrous Oxide

Nitrous oxide irreversibly oxidizes the cobalt atom in cobalamin, inactivating methionine synthase. The result is a functional B12 deficiency:

Treatment: stop exposure, give parenteral B12, and supplement methionine and folate; some clinicians add methylcobalamin. Recovery depends on duration of exposure; early treatment can reverse substantial deficit, prolonged exposure often cannot. Large-tank nitrous products sold in convenience stores have driven a marked rise in these presentations.

---

5. Alkyl Nitrites

• Methemoglobinemia: cyanosis unresponsive to oxygen, chocolate-brown blood, a saturation gap between pulse oximetry and measured arterial oxygen saturation. Treat with methylene blue 1 to 2 mg/kg IV (avoid in G6PD deficiency, where ascorbic acid or exchange transfusion is used).
• Absolute interaction: nitrites plus PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) produce profound, refractory hypotension. This is a required counseling point for any patient who reports popper use, and it intersects heavily with sexualized stimulant use.
• Retinal toxicity: maculopathy with central vision loss has been reported with isopropyl nitrite formulations.

---

6. Assessment and Treatment

• Ask specifically. Inhalant use is rarely volunteered. Ask about "huffing, bagging, dusting, whippets, poppers" by name. Peak prevalence is in early adolescence, and use often declines with age — the inverse of most substances.
• Physical clues: perioral or perinasal rash ("glue sniffer's rash"), paint on hands or clothing, chemical odor on breath, frostbite burns, conjunctival injection.
• Laboratory: basic metabolic panel with anion gap calculation, potassium, creatine kinase, liver enzymes, methylmalonic acid and homocysteine when nitrous oxide is suspected, methemoglobin level for nitrites, carboxyhemoglobin for methylene chloride. Routine urine drug screens do not detect inhalants.
• Withdrawal: a mild syndrome (irritability, nausea, tremor, sleep disturbance) is described with heavy chronic solvent use but is not dangerous and requires only supportive care.
• Treatment: no approved pharmacotherapy. Management is family-based and environmental — removing access, treating co-occurring conditions, addressing the developmental and social context, and family therapy. Prognosis is strongly tied to how quickly exposure stops, because the neurologic injuries do not reverse.